AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon…